Millstone Evans Group, LLC Novavax Inc Transaction History
Millstone Evans Group, LLC
- $147 Billion
- Q4 2024
A detailed history of Millstone Evans Group, LLC transactions in Novavax Inc stock. As of the latest transaction made, Millstone Evans Group, LLC holds 400 shares of NVAX stock, worth $3,272. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400Holding current value
$3,272% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVAX
# of Institutions
287Shares Held
90.9MCall Options Held
6.98MPut Options Held
9.57M-
Vanguard Group Inc Valley Forge, PA15.7MShares$129 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$96.9 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$91.2 Million35.54% of portfolio
-
State Street Corp Boston, MA7.69MShares$62.9 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.94MShares$48.6 Million0.07% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $640M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...